Re. Goldstein et al., PROGNOSIS AFTER HOSPITALIZATION FOR ACUTE MYOCARDIAL-INFARCTION NOT ACCOMPANIED BY TYPICAL ISCHEMIC CHEST PAIN, The American journal of medicine, 99(2), 1995, pp. 123-131
PURPOSE: Although ischemic-type chest pain generally identifies acute
myocardial infarction (AMI), some patients are hospitalized for AMI wi
thout this symptom. Long-term mortality and morbidity after AMI presen
ting with alternative warning symptoms have not been examined previous
ly. We therefore assessed the prognostic implications of the absence o
f typical chest gain as well as other recognized risk predictors in pa
tients hospitalized with AMI. PATIENTS AND METHODS: Data were obtained
during the Multicenter Diltiazem Postinfarction Trial. Pain status an
d other baseline characteristics were determined prospectively by stud
y coordinators according to simple, prespecified criteria. Patients we
re then examined every 3 to 4 months until trial completion. We applie
d chi-square methods, life-table analysis, and multivariate analysis t
o assess the strength and independence of prognostic power associated
with each baseline variable. RESULTS: Of 2,464 patients enrolled 3 to
15 days after enzyme-documented AMI, 115 patients lacked typical ische
mic-type chest pain on presentation (the ''nonpainful'' group). After
25 months' mean follow-up, cardiac mortality was 20% for nonpainful pa
tients and 10% for 2,349 patients with typical pain (the ''painful'' g
roup), P <0.001. Similar increments were seen in total deaths (27% non
painful versus 13% painful, P <0.001) and cardiac events, namely, card
iac death or nonfatal reinfarction (24% nonpainful versus 17% painful,
P = 0.001). Late congestive heart failure was more frequent (17% nonp
ainful versus 7% painful, P <0.001), but unstable angina was less (6%
nonpainful versus 16% painful, P = 0.005). At outset, nonpainful patie
nts had more left ventricular dysfunction and diabetes mellitus. Howev
er, nonpainful AMI predicted worse outcome even when these problems we
re absent. Logistic regression confirmed greater cardiac death risk in
the nonpainful group (hazard ratio = 2.05) and showed that predictive
power of nonpainful status was independent of baseline ejection fract
ion, Holter data, concomitant diabetes mellitus, and other covariates.
CONCLUSIONS: Patients hospitalized with nonpainful AMI are much more
likely to experience late cardiac death or congestive heart failure th
an are patients with painful AMI. In part, this probably reflects more
ventricular damage with alternative warning symptoms such as dyspnea.
However, our data suggest that defective perception of warning pain a
lso provides a long-term risk to life that is independent of previousl
y known predictors of poor outcome.